Pennsylvania: Patients Respond to Recall of Medical Cannabis Products, Say Such Incidents Strengthen Arguments to Permit Home Cultivation 

The following press release was drafted by Chris Goldstein and Jeff Riedy on behalf of Lehigh Valley NORML On Friday, February 4, 2022, the Pennsylvania Department of Health (PaDOH) Medical Marijuana Program (MMP) issued the first large product recall in the program’s history. There is a long list of affected products; all of them are […]

Health Policy Must be Driven by Evidence, Not Dictated by Clickbait

New York, NY – February 9, 2022 – Today, in response to the Department of Health and Human Services (HHS) and Office of National Drug Control Policy’s statement that they will no longer be allowing federal funding to go towards putting pipes in safer smoking supplies, Kassandra Frederique, Executive Director of the Drug Policy Alliance, […]

What’s the Future of Marijuana Legalization in Oklahoma?

There are currently  three ballot initiatives and dozens of marijuana-related bills pending in Oklahoma. Oklahomans for Responsible Cannabis Action (ORCA), the same group responsible for drafting the successful 2018 medical initiative, is seeking to place two initiatives on the ballot this fall.  SQ 818, known as the Oklahoma Medical Marijuana Enforcement and Anti-Corruption Act, seeks […]

Senate Majority Leader Provides Timeline for Introducing Long-Awaited Marijuana Descheduling Plan

US Senate Majority Leader Chuck Schumer announced at a press conference on Friday that he intends to formally introduce the Cannabis Administration and Opportunity Act (CAOA) in April. The forthcoming legislation, which was released in draft form last July, repeals federal marijuana prohibition by removing cannabis from the US Controlled Substances Act. Speaking at the […]

State Policy Weekly Update (2/4/22)

Here is NORML’s weekly update on state legislative activity. Highlights  Mississippi Becomes the 37th State to Provide Medical Cannabis Access The Mississippi Medical Cannabis Act (SB2095) became law on Wednesday . SB2095 regulates the production and distribution of cannabis flowers and concentrates to patients with cancer, refractory pain, post-traumatic stress, spinal cord disease, and other […]

Utah: Lawmakers Advance Bill to Governor’s Desk Protecting State Employees From Workplace Discrimination for Medical Cannabis Use

Lawmakers in the Utah House and Senate have overwhelmingly approved legislation, Senate Bill 46, protecting state employees from being sanctioned in the workplace for their off-the-job use of medical cannabis. Members of the Senate passed the measure by a vote of 26 to 1. House members advanced the measure 68 to 4. It now awaits […]

Mississippi Becomes 37th State to Provide Medical Cannabis Access

Legislation became law today allowing for qualified patients to obtain medical cannabis products from licensed providers.  Senate Bill 2095: The Mississippi Medical Cannabis Act regulates the production and distribution of cannabis flowers and concentrates to patients with cancer, refractory pain, post-traumatic stress, spinal cord disease, and other qualifying ailments. It is the 37th state to […]

South Dakota: Lawmakers Reject Legislative Efforts to Restrict Medical Cannabis Access

State lawmakers have rejected a series of legislative proposals that sought to curtail how and where patients could access and use medical cannabis. Specifically, members of the Senate Health and Human Services Committee voted 4 to 2 against House Bill 1004, which sought to repeal provisions from the state’s voter-approved medical cannabis law that permit qualified patients […]

1 58 59 60 61 62 314
Right Menu Icon